Jun 13, 2016
TD 1607
TD-1607 Phase I A glycopeptide-cephalosporin heterodimer potentially for the treatment of gram-positive bacterial infection. CAS No. 827040-07-3 C95 H109 Cl3 N18 O31 S2, Molecular Weight, 2169.47 Vancomycin,…
View On WordPress
seen from India
seen from Germany
seen from Australia
seen from United Kingdom
seen from Yemen
seen from India
seen from Singapore
seen from Yemen
seen from United States
seen from Yemen
seen from Spain
seen from China
seen from Türkiye
seen from United States
seen from United States
seen from Malaysia
seen from India
seen from United States
seen from Yemen
seen from United States
TD 1607
TD-1607 Phase I A glycopeptide-cephalosporin heterodimer potentially for the treatment of gram-positive bacterial infection. CAS No. 827040-07-3 C95 H109 Cl3 N18 O31 S2, Molecular Weight, 2169.47 Vancomycin,…
View On WordPress
TD 1607
TD-1607
Phase I
A glycopeptide-cephalosporin heterodimer potentially for the treatment of gram-positive bacterial infection.
CAS No. 827040-07-3
C95 H109 Cl3 N18 O31 S2, Molecular Weight, 2169.47 Vancomycin, 29-[[[2-[[6-[[[1-[[(6R,7R)-7-[[(2Z)-2-(2-amino-5-chloro-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-e…
View On WordPress